Stock Market & Financial Investment News

News Breaks December 20, 2012 08:45 EDT FOLD Amicus Theraputics downgraded to Hold from Buy at Capstone Capstone downgraded Amicus following the failure of its pivotal study 011 of Amigal monotherapy in Fabry disease. Price target $3. News For FOLD From The Last 14 Days Check below for free stories on FOLD the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. June 17, 2013 11:45 EDT FOLD Amicus Theraputics price target lowered to $3 from $4 at Leerink Subscribe for More Information 09:19 EDT FOLD On The Fly: Pre-market Movers Subscribe for More Information 09:04 EDT FOLD Amicus delays U.S. filing Amigal unit late 2014, TheStreet reports Subscribe for More Information 06:09 EDT FOLD Amicus Theraputics to host conference call Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.